| human | Q5 |
| P244 | Library of Congress authority ID | n2009182695 |
| P214 | VIAF ID | 305691672 |
| P106 | occupation | physician | Q39631 |
| Q36984261 | A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma |
| Q37119876 | A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial |
| Q38375057 | A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia |
| Q33423350 | ADAMTS13 Endopeptidase Protects against Vascular Endothelial Growth Factor Inhibitor-Induced Thrombotic Microangiopathy |
| Q61456104 | AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts |
| Q57477623 | AP39, a modulator of mitochondrial bioenergetics, reduces anti-angiogenic response and oxidative stress in hypoxia-exposed trophoblasts: relevance for preeclampsia pathogenesis |
| Q37777854 | Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia |
| Q46650341 | Accuracy of angiogenic biomarkers at ⩽20weeks' gestation in predicting the risk of pre-eclampsia: A WHO multicentre study |
| Q36089390 | Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals |
| Q40132624 | Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival |
| Q55417813 | Acute Homeostatic Changes Following Vitamin D2 Supplementation. |
| Q43796743 | Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokine |
| Q37215562 | Advances in the understanding of eclampsia |
| Q37632878 | Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors |
| Q47174563 | Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis |
| Q55025576 | Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy. |
| Q33703272 | Angiogenic dysfunction in molar pregnancy |
| Q37621251 | Angiogenic factor abnormalities and fetal demise in a twin pregnancy |
| Q36421501 | Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| Q36287399 | Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia |
| Q34714082 | Angiogenic factors and preeclampsia |
| Q35871381 | Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia |
| Q54613364 | Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. |
| Q36526596 | Angiogenic factors in preeclampsia and related disorders |
| Q36339288 | Angiogenic factors in the pathogenesis of preeclampsia |
| Q35941009 | Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights |
| Q33349183 | Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia |
| Q24311749 | Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium |
| Q36994658 | Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis* |
| Q35877155 | Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis |
| Q54578925 | Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period. |
| Q36035526 | Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients |
| Q34169172 | Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women |
| Q37280857 | Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease |
| Q36971450 | Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure |
| Q34155902 | Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model |
| Q35008096 | Cellular actions and signaling by endostatin |
| Q35597443 | Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia |
| Q47437406 | Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy |
| Q34670638 | Circulating angiogenic and antiangiogenic factors in women with eclampsia |
| Q51936330 | Circulating angiogenic factors and placental abruption. |
| Q36204596 | Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia |
| Q47217679 | Circulating angiogenic factors and the risk of preeclampsia |
| Q37186426 | Circulating angiogenic factors in gestational proteinuria without hypertension |
| Q36086665 | Circulating angiogenic factors in preeclampsia |
| Q36288766 | Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia |
| Q36148518 | Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates |
| Q36605199 | Circulating lymphangiogenic factors in preeclampsia |
| Q36953051 | Circulating soluble endoglin and placental abruption |
| Q36285862 | Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity |
| Q35738052 | Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia |
| Q37098433 | Clinical characterization and outcomes of preeclampsia with normal angiogenic profile |
| Q50061759 | Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo |
| Q61456107 | Complement 7 Is Up-Regulated in Human Early Diabetic Kidney Disease |
| Q37092330 | Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors |
| Q36507908 | Correlation of cystatin-C with glomerular filtration rate by inulin clearance in pregnancy |
| Q46387361 | Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors |
| Q45894449 | Differential immunoregulation in successful oocyte donation pregnancies compared with naturally conceived pregnancies |
| Q44200909 | Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta |
| Q52858621 | Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation. |
| Q35985870 | Early outcomes among those initiating chronic dialysis in the United States |
| Q39692302 | Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study |
| Q33850993 | Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality |
| Q36946574 | Elevated levels of placental growth factor represent an adaptive host response in sepsis |
| Q34111700 | Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. |
| Q36325183 | Endostatin is a potential inhibitor of Wnt signaling |
| Q38376237 | Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint |
| Q40268212 | Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? |
| Q36752536 | Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period |
| Q25255098 | Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans |
| Q36266464 | Excess placental secreted frizzled-related protein 1 in maternal smokers impairs fetal growth |
| Q56619493 | Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia |
| Q35950212 | Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia |
| Q35175524 | Exposure to experimental preeclampsia in mice enhances the vascular response to future injury |
| Q47770771 | Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women |
| Q42099246 | FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia |
| Q36371046 | Familial factors in the association between preeclampsia and later ESRD. |
| Q56619507 | First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia |
| Q34655258 | First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia |
| Q37178546 | First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia |
| Q33683820 | First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus |
| Q36936419 | Flt1, pregnancy, and malaria: evolution of a complex interaction |
| Q51275238 | Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. |
| Q50017347 | Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis |
| Q37191469 | Gestational age, infant birth weight, and subsequent risk of type 2 diabetes in mothers: Nurses' Health Study II. |
| Q35791024 | Hemodynamic, vascular, and reproductive impact of FMS-like tyrosine kinase 1 (FLT1) blockade on the uteroplacental circulation during normal mouse pregnancy |
| Q46150310 | Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy |
| Q49751930 | Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase |
| Q40543073 | High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis |
| Q42837825 | How does smoking reduce the risk of preeclampsia? |
| Q35318513 | Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury |
| Q37670305 | Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor |
| Q38318152 | Hydrogen sulfide: role in vascular physiology and pathology |
| Q24595773 | Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker |
| Q35807300 | Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension |
| Q35920602 | Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question |
| Q41436449 | Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia |
| Q44271036 | In vivo rat model of preeclampsia |
| Q33893203 | Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy |
| Q36162606 | Induced Human Decidual NK-Like Cells Improve Utero-Placental Perfusion in Mice |
| Q47945074 | Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia |
| Q46791681 | Interferon-alpha and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia |
| Q35236547 | Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia |
| Q39877275 | KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes |
| Q37670620 | Kidney complications: why don't statins always work? |
| Q36513300 | Late postpartum eclampsia: examples and review |
| Q37719051 | Leptin exacerbates sepsis-mediated morbidity and mortality |
| Q40206618 | Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells |
| Q40462011 | Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. |
| Q42110772 | Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis |
| Q46881114 | Low urinary placental growth factor is a marker of pre-eclampsia |
| Q28538906 | Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination |
| Q37555387 | Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension |
| Q28281326 | Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review |
| Q36796654 | Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies |
| Q35561451 | Maternal circulating angiogenic factors in twin and singleton pregnancies |
| Q63971703 | Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury |
| Q34116772 | Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery |
| Q34821237 | Midpregnancy levels of angiogenic markers in relation to maternal characteristics |
| Q35538277 | Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia |
| Q54901493 | Molecular Mechanisms of Preeclampsia. |
| Q33344105 | Molecular mechanisms of preeclampsia |
| Q42793474 | Moving forward in sepsis research |
| Q35875898 | New aspects in the pathophysiology of preeclampsia |
| Q33935675 | New developments in the pathogenesis of preeclampsia |
| Q37451322 | Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia |
| Q34365552 | Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway |
| Q40398309 | PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model |
| Q35370349 | PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice |
| Q40805033 | PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies |
| Q37676212 | Pathogenesis of preeclampsia |
| Q38337773 | Pathogenesis of preeclampsia |
| Q36910594 | Pathophysiology of the clinical manifestations of preeclampsia |
| Q54570213 | Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. |
| Q36673810 | Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension |
| Q42934449 | Placental Growth Factor as a Novel Marker in Uremia-Related Cardiovascular Disease |
| Q44121356 | Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia |
| Q38374754 | Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes |
| Q37758589 | Placental vasculature in health and disease |
| Q34461130 | Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia |
| Q37182006 | Plasma gelsolin and circulating actin correlate with hemodialysis mortality |
| Q37615825 | Pre-eclampsia and cardiovascular disease |
| Q37424540 | Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study |
| Q33275899 | Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy |
| Q36584747 | Preeclampsia and Pregnancy-Related Hypertensive Disorders |
| Q36971766 | Preeclampsia and angiogenic imbalance |
| Q40463349 | Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. |
| Q47665000 | Preeclampsia and retinopathy of prematurity in preterm births |
| Q34920271 | Preeclampsia and the Anti-Angiogenic State |
| Q42773699 | Preeclampsia and the kidney: footprints in the urine |
| Q33924175 | Preeclampsia and the risk of large-for-gestational-age infants |
| Q46727905 | Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung |
| Q35143007 | Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease |
| Q36627811 | Preeclampsia, gestational hypertension and subsequent hypothyroidism |
| Q39436561 | Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications |
| Q36120940 | Preeclampsia: a renal perspective |
| Q37512886 | Preeclampsia: the role of angiogenic factors in its pathogenesis |
| Q35167070 | Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats |
| Q38565163 | Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study |
| Q51801232 | Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. |
| Q34403945 | Protein carbamylation in kidney disease: pathogenesis and clinical implications |
| Q35667666 | Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease |
| Q36255904 | Recent advances in understanding of preeclampsia. |
| Q34775094 | Receptor tyrosine kinase Tie-1 overexpression in endothelial cells upregulates adhesion molecules |
| Q64377002 | Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia |
| Q33666742 | Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension |
| Q41643100 | Reduction of carbamylated albumin by extended hemodialysis |
| Q39633468 | Regulation of placental growth by aldosterone and cortisol |
| Q36433038 | Regulatory T cells in preeclampsia: some answers, more questions? |
| Q51206012 | Relationship between hypoxia and downstream pathogenic pathways in preeclampsia. |
| Q54392576 | Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. |
| Q36624730 | Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia |
| Q54518052 | Response to "Are aldosterone levels inappropriately low in preeclampsia"? |
| Q54334562 | Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia". |
| Q53075191 | Revisiting decidual vasculopathy. |
| Q44232061 | Risk for developing gestational diabetes in women with twin pregnancies |
| Q57172327 | Risk of Preeclampsia and Pregnancy Complications in Women With a History of Acute Kidney Injury |
| Q48672635 | Role of oxidative stress and antioxidant supplementation in pregnancy disorders |
| Q36034224 | Second trimester anti-angiogenic proteins and preeclampsia |
| Q51914188 | Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. |
| Q40039628 | Sequential plasma angiogenic factors levels in women with suspected preeclampsia |
| Q44112633 | Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women |
| Q40531885 | Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury |
| Q49791319 | Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging |
| Q47863005 | Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage |
| Q28244090 | Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia |
| Q53497854 | Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. |
| Q53600812 | Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. |
| Q28244053 | Soluble endoglin contributes to the pathogenesis of preeclampsia |
| Q33532601 | Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease |
| Q37042332 | Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia |
| Q44111229 | Spiral artery remodeling in preeclampsia revisited |
| Q34803030 | Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors |
| Q35748662 | The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients |
| Q35661796 | The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia |
| Q37489857 | The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes |
| Q36883342 | The glomerular injury of preeclampsia |
| Q48210918 | The pathology of eclampsia: An autopsy series |
| Q37995181 | The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia |
| Q33385942 | The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome |
| Q34590067 | Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis, a complication of chronic peritoneal dialysis |
| Q35871466 | Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia |
| Q38784644 | Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. |
| Q54551217 | Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? |
| Q46345253 | Uric acid and preeclampsia |
| Q35742936 | Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link |
| Q36009495 | Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea |
| Q36502881 | VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma |
| Q40383970 | Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion |
| Q39185420 | Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia |
| Q54542851 | Vasculitis is an antiangiogenic state. |
| Q30793329 | Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study |
| Q35955480 | Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship |
| Q28506573 | WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier |
| Q33675979 | Welles et al. respond to "Low vitamin D and cardiovascular disease" |
| Q35853296 | eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype |
Search more.